soul trial oral semaglutide cardiovascular outcomes 2024 nejm results Cardiovascular Outcomes, Safety, and Tolerability With Oral Semaglutide: Insights for Managed Care SOUL (Semaglutide cardiOvascular oUtcomes triaL)
Description
Asegrate de informar a tu mdico sobre tu historial clnico completo y cualquier otro tratamiento que ests tomando actualmente
While calculations of NNT cannot replace cost-effectiveness analyses, they can provide insight for a range of stakeholders in the healthcare system
The company also offers ongoing support and communication with medical professionals as you begin and go through your treatment
To me, this suggests lower doses are placebo-like
Semaglutide is a GLP-1 receptor agonista medication that mimics glucagon-like peptide-1 (GLP-1), a natural hormone in your body
